Robert Glazer

Changes in Brain Natriuretic Peptide and Norepinephrine Over Time and Mortality and Morbidity in the Valsartan Heart Failure Trial (Val-HeFT)

Inder S. Anand, Lloyd D. Fisher, YannTong Chiang et al. · Circulation · 2003 · 860 citations

C-Reactive Protein in Heart Failure

Inder S. Anand, Roberto Latini, Viorel G. Florea et al. · Circulation · 2005 · 444 citations · Full text

Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: Results from the Valsartan Heart Failure Trial (Val-HeFT)

Aldo P. Maggioni, Roberto Latini, Peter E. Carson et al. · American Heart Journal · 2005 · 409 citations

Heart Failure, Cardiac Anaesthesia, Cardiovascular Disease +10

Anemia and Change in Hemoglobin Over Time Related to Mortality and Morbidity in Patients With Chronic Heart Failure

Inder S. Anand, Michael A. Kuskowski, Thomas S. Rector et al. · Circulation · 2005 · 290 citations

Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension

Thomas Philipp, Timothy R. Smith, Robert Glazer et al. · Clinical Therapeutics · 2007 · 260 citations

Hypertension, Cardiovascular Disease, Antihypertensive Therapy +8